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Denmark, Lyngby, DenmarkABSTRACT The partitioning of the wasp venom peptide mastoparan-X (MPX) into neutral and negatively charged lipid
membranes has been compared with two new synthetic analogs of MPX where the Na-terminal of MPX was acylated with prop-
anoic acid (PA) and octanoic acid (OA). The acylation caused a considerable change in the membrane partitioning properties of
MPX and it was found that the shorter acylation with PA gave improved affinity and selectivity toward negatively charged
membranes, whereas OA decreased the selectivity. Based on these findings, we hypothesize that minor differences in the
embedding and positioning of the peptide in the membrane caused by either PA or OA acylation play a critical role in the
fine-tuning of the effective charge of the peptide and thereby the fine-tuning of the peptide’s selectivity between neutral and
negatively charged lipid membranes. This finding is unique compared to previous reports where peptide acylation enhanced
membrane affinity but also resulted in impaired selectivity. Our result may provide a method of enhancing selectivity of antimi-
crobial peptides toward bacterial membranes due to their high negative charge—a finding that should be investigated for other,
more potent antimicrobial peptides in future studies.INTRODUCTIONAntimicrobial peptides (AMPs) offer themselves as poten-
tial drugs for treating bacterial, fungal, and viral infections
and thus as a new class of antibiotics. In the 1990s, a large
number of new antimicrobial peptides were discovered and
the potential of these peptides as a first line of defense
against microorganisms in higher eukaryotes such as plants
and vertebrates, including humans (1) resulted in consider-
able research efforts in this area. However, AMPs have
not yet been able to fulfill early hopes for substituting clas-
sical antibiotics in the treatment of infections by multiresist-
ant bacteria, inasmuch as greater bacterial membrane
selectivity and in vivo stability has to be achieved.
AMPs share a set of common biophysical characteristics
that are crucial for their antimicrobial activity. They are
relatively small, ranging from 10 to 40 amino acids in
size, have a net positive charge (usually between þ2
and þ9), and form a-helices or b-sheets upon interaction
with lipid membranes (2). The structural transition is
driven by the formation of an amphipathic structural
arrangement that results in a face displaying the hydro-
phobic amino acids allowing embedment into the hydro-
phobic part of the membrane interface and a positively
charged face allowing favorable interaction with the
phospholipid headgroups. Electrostatic attraction of the
positively charged AMPs to the negatively charged micro-
bial surfaces, e.g., due to lipopolysaccharides in Gram-
negative bacteria (3), is also a very important driving forceSubmitted October 6, 2010, and accepted for publication November 23,
2010.
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This specificity is furthermore assisted by the large cho-
lesterol content of the mammalian plasma membrane,
which hampers peptide insertion and thus diminishes its
activity (4).
The mode of action of the AMPs on bacterial membranes
is not clearly understood and is AMP-dependent, but several
mechanisms have been proposed: lysis or pore formation
where several models exist (toroidal, barrel-stave, and
carpet model (5,6)), and topology alterations and lipid
segregation (7,8). To achieve improved selectivity toward
bacterial membranes over mammalian cell membranes,
a number of strategies have been investigated:
1. Increasing positive charge (9).
2. Modifying hydrophobicity and hydrophobic moment
(10,11).
3. Stabilization/destabilization of secondary structure
(12–14).
Together these studies reveal that the antibacterial and
hemolytic properties of AMPs are governed by a delicate
balance of hydrophobic and electrostatic interactions
between the peptide and the target lipid membrane, and
that the formation of secondary structure plays a crucial
role for the AMP’s mode of action. This has been exempli-
fied by Dathe et al. (15) for Magainin-II analogs where
optimization of charge and hydrophobicity resulted in
a considerable opening of the therapeutic window when
compared to the native peptide.
Another route for AMP optimization is modulation of the
peptide’s hydrophobicity by N- or C-terminal acylation
(16–20). The focus of such studies has mainly been on the
long fatty acid chains, such as lauroyl, myristoyl, anddoi: 10.1016/j.bpj.2010.11.040
400 Etzerodt et al.palmitoyl, which have been shown to stabilize secondary
structure formation (17,18,21,22), improve membrane bind-
ing, induce formation of lipopeptide aggregates/micelles
(23), and improve endotoxin/lipopolysaccharides neutrali-
zation/binding (20,24,25). Although a few studies have
been reported focusing on a broad range of acylation chain
lengths, the conclusions have been that the longer chains
such as lauroyl showed the largest potency; however,
without monitoring the possible change in lytic activity,
the conclusions can be misleading (21,26).
Even though AMP acylation has provided promising
results, e.g., yielding an increased antimicrobial and anti-
fungal activity toward a broad range of bacterial strains
and fungi (17,20,27), it has also resulted in an unwanted
increase in hemolytic activity of the acylated analogs and
an overall reduction of the therapeutic window. This issue
is related to the missing membrane selectivity of the acyl
chain, which for larger chains completely impairs the
peptide membrane selectivity. Hence, acylation with long
fatty acids has not led to the necessary selectivity toward
bacterial membranes, and further studies of how acylation
affects the AMP membrane selectivity on a fundamental
level are of great importance.
In this article, we focus on short-chain acylations of mas-
toparan-X (MPX), and study the details of how these
modifications alter the electrostatic and hydrophobic contri-
bution to membrane-binding affinity toward negatively
charged and neutral model membranes mimicking bacterial
and mammalian cell membranes, respectively. MPX is a
14-amino-acid peptide with a net positive charge of þ4
that belongs to the mastoparan (MP) family of antimicrobial
peptides, and is found in high concentration in wasp venom
(28). It mainly occurs as a random coil in solution and
forms an a-helix when interacting with a lipid membrane
interface. MPX shows considerable antimicrobial activity
against Gram-positive bacteria and stimulates phospholi-H
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FIGURE 1 Chemical structure of the Mastoparan-X (MPX) peptide and its N-t
R ¼ n-octanoyl, OA-MPX).
Biophysical Journal 100(2) 399–409pase A2 activity (29); however, MPX also shows substantial
hemolytic activity.
We hypothesized that short fatty acid chains can provide
enhanced selectivity toward negatively charged membranes
when compared to zwitterionic lipid membranes, and that
longer fatty acid chains result in reduction of selectivity
due to a high hydrophobic contribution to the free energy
(inasmuch as binding is mediated by the fatty acid).
However, because acylation has been shown to stabilize
secondary structure, the decoupling of the different effects
on the membrane is complex. To evaluate this hypothesis,
we have investigated the MPX affinity toward neutral and
negatively charged lipid membranes using fluorescence
spectroscopy, and compared MPX to two new synthetic
analogs of MPX where the Na-terminal of MPX was acyl-
ated with propanoic acid (PA) and octanoic acid (OA) (see
Fig. 1). The secondary structure of MPX and its analogs
were furthermore investigated by circular dichroism (CD).MATERIALS AND METHODS
Materials
All Fmoc (9H-fluoren-9-yl-methyloxycarbonyl) L-amino acids were
purchased from GLS China (GL Biochem, Shanghai, China). Lys and
Trp were side-chain-protected as tert-butoxycarbonyl. Asn was side-
chain-protected with trityl. TFA (trifluoroacetic acid); TIS (triisopropylsi-
lane); HEPES (N-(2-hydroxyethyl)piperazine-N0-(2-ethanesulfonic acid));
HEPES-Na, the corresponding sodium salt; propanoic acid (~99% pure);
and n-octanoic acid (R98% pure) were purchased from Sigma-Aldrich
(Brøndby, Denmark). NaCl was purchased from J.T. Baker Chemicals
(Mallinckrodt Baker, Griesheim, Germany).
Extrusion filter supports and Hamilton extrusion syringes (Avanti Polar
Lipids, Alabaster, AL), POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-[phos-
pho-rac-(1-glycerol)] sodium salt), and POPC (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine) were purchased from Avanti Polar Lipids
(Alabaster, AL). All compounds were used without further purification.
Membrane filters for extrusion (100-nm pore size, polycarbonate) were
purchased from Whatman (Maidstone, UK). Cuvette (4  10 mm, quartz,H
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Membrane Partitioning of MPX and Acyl Analogs 401Suprasil) was purchased from Hellma (Mu¨llheim, Germany). Purified
human erythrocytes for the hemolysis studies were provided by Bioneer
(Hørsholm, Denmark), and were stored at 4C for a maximum of three
days before use.Peptide synthesis and purification
The peptideswere synthesizedmanually onRink amide resin using the Fmoc
strategy.Coupling stepswere carried outwithHATU(2-(1H-7-azabenzotria-
zol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate) þ DIPEA
(diisopropylethylamine) or HOAt (1-hydroxy-7-aza-benzotriazole) þ DIC
(diisopropylcarbodiimide) in NMP (N-methylpyrrolidone). Coupling of
each amino acid and Fmoc deprotection was monitored using the ninhydrin
test.
Peptides were cleaved from the resin in a mixture of TFA/H2O/TIS
(95:2.5:2.5) and precipitated by addition of water. The resulting slurry
was concentrated in vacuo, lyophilized, and the crude peptides were puri-
fied by preparative high-performance liquid chromatography (HPLC).
(Smartline unit. Components: Manager 5000, Pump 1000, UV Detector
2500. Column: Eurospher-100 C18 column (20  250 mm) with integrated
precolumn; flow ¼ 10 mL/min; temperature ¼ 20C. Both provided by
Knauer, Berlin, Germany. The purity of the peptides was assessed by
analytical HPLC. (Elite Lachrom system, Components: L-2100 pump,
L2450-DAD, L-2200 Autosampler; Hitachi, Chula Vista, CA. Column:
Luna 3u, reverse phase C18, 100 A˚ (2.0  100 mm) without precolumn;
flow ¼ 0.25 mL/min; temperature ¼ 30C; Phenomenex, Torrance, CA).
Unique linear gradients were used for the three different peptides. Mobile
phases were A: 5% MeCN, 0.1% TFA; mobile phase B: 95% MeCN, 0.1%
TFA. Confirmation of peptide identity was performed by mass spectrometry
(Esquire model ion trap mass spectrometer, ESI in positive mode; Bruker
AXS, Bremen, Germany). (Parameters: m/z scan range 50–3000; nebulizer
pressure ¼ 30 psi; dry gas flow ¼ 8 L/min; dry gas temperature ¼ 350C;
capillary voltage ¼ 3.5 kV; trap drive level ¼ 80%.)Preparation and characterization of large
unilamellar vesicles
POPC and POPC/POPG (3:1) lipid films were prepared by evaporation
from CHCl3/MeOH (9:1) using a gentle stream of argon. The residual
organic solvent was evaporated in vacuum overnight and the lipid films
were subsequently hydrated in HEPES buffer (10 mM HEPES, 100 mM
NaCl, pH ¼ 7.4) at room temperature with vigorous stirring every 5 min.
The multilamellar lipid suspension was extruded into 100-nm liposomes
using a mini-extruder (Avanti Polar Lipids). The size of the liposomes
was characterized by dynamic light scattering (Zetasizer Nano; Malvern
Instruments, Worcestershire, UK) and phosphorus analysis was conducted
using ICP-AES (Vista AX; Varian, Cary, NC).Fluorescence measurements
Fluorescence measurements were carried out on a model No. F900 fluores-
cence spectrometer (Edinburgh Instruments, Livingston, UK) equipped
with single-grating emission and excitation monochromators. Tryptophan
was excited at 280 nm, and emission scans were acquired from 300 to
400 nm with 1-nm step size. The excitation and emission monochromators
were adjusted to a spectral bandwidth of 6 nm and 16 nm, respectively, and
the angles of the polarizers were adjusted to Empol ¼ 90 and Expol ¼ 0 in
accordance with Ladokhin et al. (30). Quartz cuvettes with an excitation
pathway of 10 mm and an emission pathway of 4 mm were used to mini-
mize scattering effects. A quantity of 1000 mL of a 20-mM peptide solution
was prepared directly in the cuvette.
The partitioning experiments were conducted at concentrations below the
critical micelle concentration of the peptides. Temperature was maintained
at 37C via an external water bath throughout the experiments. Increasingvolumes of large unilamellar vesicle (LUV) suspension were titrated into
the peptide solution. Magnetic stirring was applied to obtain rapid equili-
bration of the system during each titration. Scattering effects were cor-
rected-for by titration experiments with L-Trp solution using equivalent
experimental conditions as used for the titration of peptide. Because the
partitioning of L-Trp into LUVs is negligible, changes in fluorescence for
this correction experiment should arise from scattering only (30). The
data analysis was based on fluorescence intensities recorded at 335 nm to
achieve optimal signal/noise ratio of the scatter-corrected intensities. The
buffer used for all experiments was 10 mM HEPES buffer containing
100 mM NaCl, pH 7.44.Circular dichroism
CD spectra were recorded on a Chirascan CD spectrometer (Applied Photo-
physics, Leatherhead, UK). A one-nanometer resolution and scan speed of
20 s pr.nm was applied. All measurements were carried out at 37C. For
measurements of peptide in buffer, a quartz cuvette with path length of
1 mm was used. All other measurements were carried out using 0.5 mm
platelets. Corresponding measurements without peptide were recorded as
a background signal and subtracted from the averaged raw signal from
measurements with peptide. Data fitting was carried out via the online
CDPro program suite supplied by Colorado State University (http://lamar.
colostate.edu/~sreeram/CDPro/) and the results are reported as averages
from using their Selcon3, CDSSTR, and CONTINLL programs. The
regular and distorted a-helical segments were collected as ‘‘helical’’ and
the regular and distorted b-sheet and turns were collected as ‘‘sheets and
turns.’’Hemolysis assay
AVICTOR3 1420Multilabel Counter (Perkin-Elmer, Skovlunde, Denmark)
was used for absorbance measurements in the hemolysis studies. Absor-
bance was measured at 570 nm with a measuring time of 0.1 s for each
sample. HEPES buffer (10 mM, 150 mM NaCl, pH 7.37) was used for
all procedures. Aliquots of erythrocyte solutions were transferred to
15 mL centrifuge tubes and centrifuged at 4500g, at 4C for 20 min, and
the supernatant was removed. The resulting pellets were washed with five
volumes of HEPES buffer and then centrifuged as described above to
remove the supernatant. This washing procedure was repeated three times
to remove all supernatant hemoglobin.
A quantity of 100 mL of a 4% solution (v/v) of erythrocytes in buffer was
added to individual 1.5 mL Eppendorf tubes containing 100 mL of different
concentrations of peptide solution. Final concentrations of the three
peptides were 200 mM, 150 mM, 100 mM, 75 mM, 50 mM, 25 mM,
12.5 mM, 6.25 mM, and 3.125 mM. A quantity of 10% triton X-100 in
Milli-Q (Millipore, Østerbro, Denmark) and pure buffer were used as posi-
tive and negative references, respectively. The tubes were incubated for 1 h
at 37C. Subsequently, the tubes were centrifuged at 4500g at 4C for
20 min, and 100 mL of the supernatant was mixed with 200 mL of buffer
placed in a 96-well flat-bottomed microtiter plate. The degree of hemolysis
was calculated according to the equation
Hemolysis ¼ Apeptide  Aneg:ref
Apos:ref  Aneg:ref ; (1)
where Apeptide, Aneg.ref, and Apos.ref are the absorbance of the peptide sample,
negative reference, and positive reference, respectively.THE MEMBRANE PARTITION MODEL
The distribution of amphipathic molecules between the
lipid membrane interfaces and the aqueous phase can be
described by partition equilibrium models where theBiophysical Journal 100(2) 399–409
402 Etzerodt et al.molecules can reside in either the membrane or the aqueous
phase. The concept of membrane partitioning, however, is
clearly different from that of molecular binding due to the
lack of specific binding sites on the membrane. The free
energy governing partitioning can be decomposed into
several contributions depending on the interactions of the
partitioning agent with its environment (31–33). When
considering partitioning of charged amphipathic peptides
into neutral or charged lipid membranes, the electrostatic
interactions influence the partitioning process in a complex
manner, due to the direct influence of the peptide on the
membrane surface charge density (s).
The following presentation of the membrane peptide par-
titioning process is divided into two steps (see Fig. 2):
1. A translation of the peptide from bulk into close prox-
imity of the membrane.
2. Insertion of the peptide into the lipid membrane concom-
itant with formation of peptide secondary structure.
In Step 1, the electrostatic potential experienced by the
peptide increases as a result of the closer proximity of
the charged lipid membrane, which causes a change in the
free energy:
DGE ¼ zF4s:
The charge of the peptide is given by z, F is the Faraday
constant, and 4s is the electrostatic potential evaluated at
the membrane surface.
In Step 2, the peptide inserts into the lipid membrane,
exposing its hydrophobic residues to the hydrophobic core
of the bilayer—a process that can be facilitated by formation
of secondary structure of the peptide (34–36). The freeFIGURE 2 Illustration of the peptide insertion process proceeding in two
steps. In Step 1, the peptide is transported into close proximity of the
membrane followed by Step 2, where the peptide embeds in the membrane
concomitant with the formation of an a-helical structure. The free energies
governing Steps 1 and 2 and the overall process is given by DGE, DGins, and
DGo, respectively.
Biophysical Journal 100(2) 399–409energy change of Step 2 is given by DGins leading to
a change in the standard free energy,
DGo ¼ DGins  zF4s;
for the overall partitioning process.
The activity of the membrane-embedded peptide (the par-
titioned state of the peptide) is given by the mole fraction
xm ¼ Cm=

Cm þ Clip

;
which is approximated by the peptide/lipid ratio r ¼ Cm/Clip
(a valid approximation for Cm << Clip). The concentration
of partitioned peptide is given by Cm and Clip is the lipid
concentration. The activity of the peptide in the aqueous
bulk (the free state of the peptide) is given by the mole
fraction
xf ¼ Cf=

Cf þ Cw

;
which is approximated by
xfzCf =Cw
(a valid approximation for Cf <<Cw). The concentration of
free peptide (peptide receding in the aqueous bulk) is given
by Cf and Cw is the molar concentration of water. Assuming
ideal mixing of the peptide in the membrane and aqueous
bulk, we arrive at the following equation governing the par-
titioning equilibrium:
xm
xf
z
rCw
Cf
¼ exp

 DGins þ zF4s
RT

¼ Kinsexp

 zF4s
RT

¼ Keff : (2)
The partition coefficients of insertion (Step 2) and the
combined partitioning process (Steps 1 and 2) is given as
Kins ¼ expð  DGins=RTÞ
and
Keff ¼ expð  DGo=RTÞ;
respectively. Note that the partition coefficients introduced
here are dimensionless but can be related to values given
by other authors when divided by Cw (37). By imposing
the constraint
Ctot ¼ Cm þ Cf ;
with Ctot being the concentration of the partitioning agent,
Eq. 2 can be rewritten as
Cm ¼ Keff ClipCtot
Cw þ Keff Clip: (3)
Given Keff, Eq. 3 provides a direct measure of the concentra-
tion of the membrane-embedded peptide as a function of the
lipid and total peptide concentration.
Membrane Partitioning of MPX and Acyl Analogs 403In the dilute regime where ideal mixing of the peptide in
the membrane and aqueous bulk can be assumed, the parti-
tioning coefficient and standard free energy of partitioning
are constants. However, in this case, the standard free
energy and the partitioning coefficient are functions of the
membrane surface potential 4s(r), which depend on the
peptide/lipid ratio, r. This complicates the interpretation of
the experimental data due to the overall functional depen-
dence of K(4s(r)) on r, a parameter that varies throughout
a titration experiment. The membrane surface potential is
related to the surface charge density by the Gouy-Chapman
equation, which, in the limit of high concentrations of
monovalent salt (C0), simplifies to (38)
4s ¼
2RT
F
sinh1

sﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
8000RTC0303r
p

: (4)
The vacuum permittivity and relative permittivity are given
by 30 and 3r, respectively. The surface charge density of the
membrane, s, measures the charge per area arising from
anionic lipids and cationic peptides, and can, by assumption
of ideal mixing and smearing of charges on the membrane
surface, be expressed as (39)
s ¼  e
alip
xanlipð1 fNaÞ  z$r
1 þ apep=alipr : (5)
The mole fraction of anionic lipids is given by xanlip. Equation
5 takes into account the reduction of the surface charge
density caused by the formation of a Stern-layer adjacent
to the anionic lipids. The fraction of anionic lipids which
is coordinated by sodium is calculated by
fNa ¼ KNaCNaexpð  F4s=RTÞ=ð1 þ KNaCNa
 expðF4s=RTÞÞ;
where CNa is the sodium concentration and KNa ¼ 0.6 M1
for PG lipids (39). The cross-sectional area of the lipid and
peptide are given by alip ¼ 70 A˚2 and apep, respectively. In
Eq. 5, the dependence on the peptide’s cross-sectional area
is not of leading order in xm, and it is thus approximated by
the area of the lipid (apepz alip) (40). Equations 2–5 consti-
tute a closed set of equations that, when Clip, Ctot, z, and K
are given, can be used to calculate the partitioned peptide to
lipid ratio, r.Connecting model and experimental data
The detection principle used in this article’s investigation of
MPX analogs is based on monitoring changes in the intrinsic
tryptophan (Trp) fluorescence upon transfer of the Trp-
residue to a less polar environment such as the lipid
membrane. Partitioning experiments are conducted by
successive additions of liposomes to peptide solutions;
however, scattering of the excitation and emitted light
caused by presence of the liposomes introduces artifactsin the experimental data that are accounted for by Ladokhin
et al. (30) and Hellmann and Schwartz (41). To minimize
such effects, the fluorescence emission spectra were
collected using cross-polarized light settings and quarts
cuvettes with reduced geometry were used (see Materials
and Methods for details). The scattering of light by LUVs
in the fluorescence partition experiments were gauged
by titration of the nonpartitioning probe L-Trp with
LUVs as described in Ladokhin et al. (30). The relative
reduction in L-Trp fluorescence emission is quantified by
the parameter
F ¼ FLTrp

Clip; l

FLTrpð0; lÞ ; (6)
where
FLTrp

Clip; l
 ¼ FrawLTrpClip; lCLTrp
and
FrawLTrp

Clip; l

are the concentration normalized and raw fluorescence
emission signals given as a function of the lipid concentra-
tion. The scatter reduction parameter (F) was measured for
both lipid systems as a function of increased lipid concentra-
tion and was subsequently represented by a third-order poly-
nomial expansion in clip
F ¼ 1 þ
X3
j¼ 1
ajC
j
lip;
which was used for correction of all partition experiments.
The successive addition of liposome into the peptide solu-
tion results in a gradual transfer of the peptide from the
free to the partitioned state. The recorded fluorescence emis-
sion spectra are thus a superposition of fluorescence emis-
sion from peptide residing in the aqueous bulk and in the
lipid membrane, as shown in Fig. 3 a.
In the remaining part of this section, the index i refer to
the ith addition of lipid. The fluorescence emission is given
as
FðiÞðlÞ ¼ xðiÞf Ff ðlÞ þ xðiÞm FmðlÞ; (7)
where
Ff ðlÞ ¼ Fð0Þraw=

Cð0ÞtotF

and
FmðlÞ ¼ FðNÞraw =

CðNÞtot F

are the scatter and concentration normalized fluorescence of
the free and membrane-associated form of the peptide,
respectively, and
FðiÞðlÞ ¼ FðiÞraw=

CðiÞtotF
Biophysical Journal 100(2) 399–409
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FIGURE 3 Plot of Trp emission spectra (a) and
the corresponding partitioning isotherm (normal-
ized fluorescence versus Clip) for the partitioning
of MPX into POPC/POPG (3:1) lipid membranes
(b). Insets c and d shows partitioning isotherms
(r versus Cf) for the partitioning of MPX, PA-
MPX, and OA-MPX into POPC and POPC/
POPG (3:1) lipid membranes, respectively. The
experiment was conducted by successive additions
of 100-nm liposomes into a 20-mM MPX solution
leading to the gradual blue shift observed in inset
a. Concentrations of POPC suspensions were
20.5 mM for MPX and 9.2 mM for PA-MPX and
OA-MPX. Concentration of POPC/POPG (3:1)
was 4.5 mM for all three MPX peptides. The pro-
cessed data of three individual experiments are
shown in inset b where the line is a simultaneous
fit of the data according to Eq. 10.
404 Etzerodt et al.is the scatter and concentration normalized fluorescence
upon the ith injection. The values
CðiÞtot; C
ð0Þ
tot ; and C
ðNÞ
tot
are the total peptide concentration evaluated at the ith,
initial, and infinite addition of liposome, respectively. The
values
FðiÞraw; F
ð0Þ
raw; and F
ðNÞ
raw
are the recorded fluorescence signals at the ith, initial, and
infinite liposome addition. Experimentally, the fluorescence
signal from the free (nonpartitioned) peptide, Ff(l), is
measured initially before addition of lipid, whereas the fluo-
rescence signal of the membrane partitioned state, Fm(l), is
probed in the final stage of the titration experiment.
However, for weak or average partitioning agents, full par-
titioning is difficult to achieve experimentally; thus, Fm(l)
has to be determined as a fitting parameter. The fraction
of free and membrane partitioned peptide is given by
x
ðiÞ
f ¼ CðiÞf =CðiÞtot
and
xðiÞm ¼ CðiÞm =CðiÞtot:
By use of Eq. 7 and the constraint,
xðiÞm þ xðiÞf ¼ 1;
the peptide/lipid ratio in the membrane can be expressed as
rðiÞ ¼ C
ðiÞ
m
C
ðiÞ
lip
¼ F
ðiÞðlÞ  Ff ðlÞ
FmðlÞ  Ff ðlÞ$
C
ðiÞ
tot
C
ðiÞ
lip
: (8)Biophysical Journal 100(2) 399–409Equation 8 provides a direct connection of the fluorescence
emission data and the model-binding isotherm, and can, by
use of Eq. 3, be rewritten in a form which is more suitable
for data fitting as
FðiÞðlÞ ¼ Ff ðlÞ þ DFðlÞ
Keff C
ðiÞ
lip
Cw þ Keff CðiÞlip
: (9)
Upon partitioning from an aqueous to a lipid phase, the
change in quantum yield of Trp is given by
DFðlÞ ¼ FmðlÞ  Ff ðlÞ:
To acquire the highest reliability in the data fitting proce-
dure, a simultaneous fit of Eq. 9 to n data sets (the index j
hereafter refers to the jth data-set number) is conducted by
least-square minimization using
c2

DGins; z;DF
ð jÞðlÞ ¼ Xn
j¼ 1
Ximax
i¼ 1
1
s2i; j
h
Fði; jÞexp ðlÞ  Fði; jÞðlÞ
i2
:
(10)
Here,
Fði; jÞexp ðlÞ ¼ Fði; jÞraw;expðlÞ=

CðiÞtotF

is the experimentally acquired, scatter, and concentration-
normalized fluorescence emission and si,j is the correspond-
ing estimate of the error. Each data set is comprised of
imax þ 1 individual Trp emission spectra (as shown in
Fig. 3 b) corresponding to the initial measurement (before
addition of lipid) and imax additions of liposome. Equation
10 is minimized analytically with respect to DF(i) (l), and
numerically with respect to z and DGins (using numerical
Membrane Partitioning of MPX and Acyl Analogs 405recipes routines such as golden section search). The parti-
tioning isotherms are shown in Fig. 3, c and d, as r
(Eq. 8) versus the free peptide concentration, Cf.RESULTS AND DISCUSSION
Fluorescence partition studies
The fluorescence partition studies of MPX, PA-MPX, and
OA-MPX into POPC or POPC/POPG (3:1) lipid membranes
(hereafter referred to as the PC/PG lipid system) reveal an
expected decrease in the free energy of insertion (DGins)
for the acylated analogs when compared to the native
form of MPX (see Fig. 4). This reduction in DGins is
observed for both the POPC and PC/PG lipid composition
of the membrane, indicating an overall increase in the
peptide hydrophobicity.
Strikingly, PA-MPX shows the largest reduction in
DGins of the two analogs when compared to the native
peptide, which contradicts the simple picture of increased
partitioning as a function of increased hydrophobicity. The
value obtained for the partitioning coefficient of MPX
into POPC lipid membranes agrees with literature reports,
Kins¼ 4000 M1 Cw¼ 2.2 105 (41). The slightly larger
partitioning coefficient reported by Hellmann and Schwarz
(41) at 20C is in accordance with the partitioning process
being exothermic (as found by isothermal titration calorim-
etry, data not shown), thus leading to increased partitioning
at lower temperatures.
The effective charge of the peptides partitioning into
POPC lipid membranes is found to be z ¼ 2.2, 1.5, and
0 for MPX, PA-MPX, and OA-MPX, respectively, demon- -30
 -35
 -40
 -45
 -50
 -55
105
106
107
108
109
1010MPX
PA-MPX
OA-MPX
ΔG
o  (
kJ
/m
ol
)
K
POPC
(step ii)
PCPG
(step ii)
PCPG
(step i+ii)
FIGURE 4 Bar diagram showing the standard free energies of partition-
ing and corresponding partition coefficients of MPX, PA-MPX, and OA-
MPX into POPC and POPC/POPG (3:1) lipid membranes. In the first two
blocks, the results are presented as DGins for partitioning into POPC and
POPC/POPG (3:1), respectively, whereas the third block is the minimum
of the overall standard free energy of partitioning into POPC/POPG (3:1)
lipid membranes, DG
PC=PG
min . Corresponding values of the standard free
energy and partitioning coefficients are given on the left- and right-hand
side y scale, respectively.strating a monotonic decline as the length of the N-terminal
acyl chain is increased. The notion of effective charge is
introduced for the model parameter z to distinguish it
from the nominal charge of the peptide. This modulation
of z is clearly observed in Fig. 3 c, where the effective
partitioning coefficient (Keff /Cw ~ dr/dCf) is found to be
independent of the liposome surface charge density and r
(because s ~ zr according to Eq. 5) for the OA-MPX
analog. Partition coefficients for the native and PA-acylated
MPX analog are reduced as more and more peptide is
inserted into the bilayer, indicating a nonzero effective
charge.
For the PC/PG lipid system, the effective charge varies
from z ¼ 1.7 to 2.8 to 0.6 for MPX, PA-MPX, and OA-
MPX, respectively, showing a maximum in z for the PA-
MPX analog. This optimum in the effective charge is not
easily explained, but is most likely a result of the complex
interplay of electrostatic and hydrophobic forces between
the peptide and lipids in the membrane interface. The
measured effective charge is considerably lower than
nominal peptide charge of 4 for MPX and 3 for PA-MPX
and OA-MPX, which is in accordance with other partition-
ing studies of amphipathic peptides (39,41). The effective
charge of MPX partitioning into POPC lipid membranes is
in accordance with the value of 2.4 obtained by Hellmann
and Schwarz (41). An inverse relationship between the
effective charge and hydrophobicity of the peptide has
previously been demonstrated by Ladokhin and White
(31). In this study, increased hydrophobicity of amphipathic
peptides leads to a reduction of the effective charge. The
results for MPX, PA-MPX, and OA-MPX are thus in accor-
dance with the observation by Ladokhin and White (31).
Only a few researchers have addressed the phenomenon
of effective charge in relation to partition experiments and
the ability of the Gouy-Chapman-Stern model to describe
electrostatics properly. A general observation is that the
Gouy-Chapman-Stern model is capable of describing parti-
tioning of nonhydrophobic compounds, e.g., ions and
peptides with mono, di, tri, and tetra valence (42). However,
for the partitioning of charged hydrophobic molecules, an
effective charge smaller than the nominal charge has to be
introduced into the model to describe the data properly.
This effect was investigated experimentally by Ladokhin
and White (31), and they found that:
1. The effective peptide charge is gradually reduced as the
hydrophobicity is increased.
2. The effective charge is equal to the nominal peptide
charge when the hydrophobic contribution to the free
energy of partitioning is zero.
In work by Stankowski (43), the effective charge dilemma
was approached theoretically by considering peptide-peptide
charge interactions on the membrane surface directly by
including finite size exclusion effects of the partitioning
ions as an extension of the Gouy-Chapman model. ThisBiophysical Journal 100(2) 399–409
1000
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391 MPX
PA-MPX
406 Etzerodt et al.approach led to the conclusion that the difference between
the effective and nominal charge can be accounted for by
finite size effects that are not included in the Gouy-
Chapman-Stern model.
In this study, the hydrophobicity of the MPX peptide is
increased by acylation which most likely leads to an altered
localization of the peptide in the hydrophobic core and
headgroup region of the lipid bilayer. The increased hydro-
phobicity of the N-terminal end of MPX may result in
deeper positioning of the charged neighboring lysine residue
(see Fig. 1) within the hydrophobic core of the bilayer,
which will result in larger charge repulsion between the
embedded peptides due to the reduced screening of charges
within the low dielectric core of the lipid membrane. More-
over, bringing charged residues deeper into the lipid
membrane results in stronger coordination of co-ions, e.g.,
chloride ions or protonation/deprotonation of Asp, Glu,
Arg, or Lys, which also contributes to the reduction of the
overall peptide charge. Major anomalies have earlier been
reported for the partitioning of hydrophobic anions into lipid
membranes (44).
The observed trend of the effective charge shown in Fig. 5
could thus be explained by the peptides’ increased hydro-
phobicity causing the peptides to reside deeper in the
membrane, which results in stronger co-ion coordination
and a decrease in the effective charge due to peptide-peptide
charge repulsion. This repulsion is seemingly reduced for
PA-MPX in the PC/PG lipid membrane due to charge
shielding by the PG lipids, probably due to a favorable posi-
tioning of the peptide in the interface region, which leads to
enhanced binding and selectivity toward the negatively
charged membrane.
The standard free energy,
DGo ¼ DGins þ zF4s;
is a function of the membrane surface potential, and is
minimal when 4s is minimal. This minimum,0
1
2
3
z  
(e
)
POPC PCPG
MPX
PA-MPX
OA-MPX
FIGURE 5 Bar plot of the effective peptide charge obtained from Trp
partition experiments of MPX, PA-MPX, and OA-MPX into POPC and
POPC/POPC (3:1) lipid membranes.
Biophysical Journal 100(2) 399–409DGomin ¼ minðDGoÞ;
defines the maximal interaction of the peptide and lipid
membrane, and occurs at the onset of partitioning where
little or no peptide has been inserted into the membrane.
The minimum of the standard free energy is shown in
Fig. 4, and is given by
DGPOPCmin ¼ DGPOPCins
and
DG
PC=PG
min ¼ DGPC=PGins þ zF4s;min
for POPC and PC/PG lipid membranes, respectively. In the
case of the PC/PG lipid membrane, 4s,min is calculated using
Eqs. 4 and 5 by setting r ¼ 0 and xanlip ¼ 0.25. In Fig. 4, it is
observed that DG
PC=PG
min follows the same trend as the corre-
sponding effective charge. The net difference in free energy
of peptide partitioning into a neutral or negatively charged
membrane ultimately serves as a measure of the peptides
propensity to select between bacterial and mammalian cell
membranes. This difference is exemplified in Fig. 6, where
the peptides’ selectivity between neutral or negatively
charged membranes is given by the ratio of partitioning
coefficients as
KPC=PGmax =K
POPC
max ;
where
Kmax ¼ exp
 DGomin=RT ¼ Cwdr=dCf jr¼ 0
defines the initial slope of the partitioning isotherms shown
in Fig. 3, c and d. In Fig. 6, an increase in selectivity is
observed for PA-MPX and a decrease in selectivity for 0.1
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FIGURE 6 Bar diagram illustrating the effects of N-terminal acylation
on the selectivity of MPX toward POPC and POPC/POPG (3:1) (PC/PG)
lipid membranes. The ratio K
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max =KPOPCmax gives the maximal factor by
which the current peptide prefers partitioning into PC/PG over POPC lipid
membranes. The ratio K
PC=PG
max =K
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max ðMPXÞ and KPOPCmax =KPOPCmax ðMPXÞ
measures the effect of N-terminal acylation on partitioning relative to
MPX into PC/PG and POPC lipid membranes, respectively.
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FIGURE 7 Plot of the hemolytic strength of MPX and the PA-MPX and
OA-MPX analog as a function of peptide concentration. LD50 values of
20 mM, 90 mM, and 170 mM are found for OA-MPX, MPX, and PA-
MPX, respectively.
Membrane Partitioning of MPX and Acyl Analogs 407OA-MPX. Additional effects of the N-terminal acylation is
presented in Fig. 6, where the ratios
KPC=PGmax =K
PC=PG
max ðMPXÞ
and
KPOPCmax =K
POPC
max ðMPXÞ
measures the change in partition coefficients relatively to
the native peptide for the PC/PG and POPC lipid system,
respectively. It is observed that PA-MPX yields the largest
relative increase for both lipid membranes whereas OA-
MPX shows reduced partitioning into PCPG lipid systems
relative to MPX. The loss in nominal and effective charge
of OA-MPX is thus not compensated by the increase in
the hydrophobicity of the peptide.Structural changes measured by CD
The secondary structure of MPX and its acylated analogs
was investigated by CD. The structures of the lipopeptides
were assessed in the free and membrane-bound form. The
CD data reveal that MPX and its acylated analogs exhibit
the same structural trend when embedded in buffer or the
lipid membrane. In buffer, the peptides are predominantly
structured as b-sheets and turns (~55%) and only minor
a-helical segment are found (~5–15%). When the peptide
embeds in a lipid membrane (POPC or PCPG), it undergoes
a structural change from b-sheet to a-helical (50–65%).
Overall, the investigated peptides are similar with respect
to structure; however, MPX is less structured than its
analogs in buffer, which can be explained by the higher
tendency for dimerization of the analogs. The increase in
a-helicity upon partitioning peptides between aqueous and
lipid membranes has previously been reported by several
research groups (34,45). The CD data does not reveal any
structural differences of the MPX analogs, supporting the
increased membrane selectivity of PA-MPX observed in
the membrane partition data.Lysis of red blood cells
The level of red blood cell hemolysis caused by the MPX
analogs was investigated as a function of peptide concentra-
tion, as shown in Fig. 7. The obtained results show that the
lytic strength of the MPX analogs follows the sequence
OA-MPX > MPX > PA-MPX, and the corresponding
LD50 values are 20 mM, 90 mM, and 170 mM for OA-
MPX, MPX, and PA-MPX, respectively. It has previously
been reported that acylation of amphipathic peptides results
in significant reductions of the LD50 values and thus more
lytic peptides (22). It has, moreover, been shown that the
change in lytic strength depends on the length of the acyl
chain. For OA-MPX, such a reduction of the LD50 is
observed when compared to the native peptide; however,for the PA-MPX analog the hemolytic strength of the
peptide is reduced. The combination of an increased selec-
tivity between anionic and neutral membranes revealed by
the membrane partition data (Fig. 6) combined with a lower
hemolytic strength opens the therapeutic window for the
PA-MPX lipopeptide analog.CONCLUSIONS
In this article, the dilemma of membrane selectivity of
AMPs is investigated. The partition properties of native
MPX have been compared with two new synthetic analogs
where the Na-terminal of MPX was acylated with propanoic
acid (PA) and octanoic acid (OA). The results reveal an
abnormally in the partitioning properties of the MPX
analogs, where PA-MPX shows a twofold increase in selec-
tivity toward charged over neutral LUVs and a 40-fold
increase in affinity toward POPC/POPG 1:3 membranes,
in comparison to the native MPX peptide. On the contrary,
the OA-MPX analog shows a 20-fold reduction in mem-
brane selectivity, and surprisingly a fivefold reduction in
affinity toward POPC/POPG 1:3 membranes. The results
demonstrate, at least for the MPX analogs in this study,
that the balance of peptide hydrophobicity and hydrophi-
licity (charge) is tightly connected to peptide performance,
and that an increased hydrophobicity can impair the
peptides’ selectivity between neutral and negatively charged
membranes.
If this behavior applies to a broader range of AMPs, then
it will be an important consideration in future attempts to
enhance AMP membrane selectivity by acylation. Our study
suggests that augmentation of the hydrophobicity of the
peptide may influence the effective charge, which ultimately
can impair the peptides’ membrane selectivity and thus
diminish the therapeutic window.
If these findings are generally applicable, the optimiza-
tion challenge of lipopeptides toward development of novelBiophysical Journal 100(2) 399–409
408 Etzerodt et al.candidates for future antibiotics could be to overcome or
diminish the inverse relationship between peptide hydro-
phobicity and effective charge. In this study, the first step
to resolve this issue has been taken by increasing both
peptide activity and selectivity. The current finding may
be specific to MPX; however, we hypothesize that the
membrane selectivity of a number of antimicrobial peptides
can be modulated by sequence-specific acylation where the
relative position of charged amino acids relative to the posi-
tion and hydrophobicity of acyl chains is important.
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